Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE).
about
Notch Signaling in Neuroendocrine TumorsNeuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive ReviewGastroenteropancreatic high-grade neuroendocrine carcinomaImaging approaches to assess the therapeutic response of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): current perspectives and future trends of an exciting field in developmentThe assessment of Ki-67 as a prognostic marker in neuroendocrine tumours: a systematic review and meta-analysis.Neuroendocrine tumors of colon and rectum: validation of clinical and prognostic values of the World Health Organization 2010 grading classifications and European Neuroendocrine Tumor Society staging systemsShould surgery be conducted for small nonfunctioning pancreatic neuroendocrine tumors: a systemic reviewClinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China.Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.Observational study of patients with gastroenteropancreatic and bronchial neuroendocrine tumors in Argentina: Results from the large database of a multidisciplinary group clinical multicenter study.Clinical, pathological and prognostic characteristics of gastroenteropancreatic neuroendocrine neoplasms in China: a retrospective study.Diagnostic accuracy of endoscopic ultrasonography for rectal neuroendocrine neoplasms.Comprehensive treatment of a functional pancreatic neuroendocrine tumor with multifocal liver metastases.Italian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms.ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors.ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.Are there any significant variations in the clinical or histological presentation of lymphoid pathologies over the course of time in Spain?Identification of metastatic cancer in claims data.Clinicopathological characteristics and prognosis-related factors of resectable pancreatic neuroendocrine tumors: a retrospective study of 104 cases in a single Chinese center.Relationship between clinical characteristics and survival of gastroenteropancreatic neuroendocrine neoplasms: A single-institution analysis (1995-2012) in South China.RABL6A promotes G1-S phase progression and pancreatic neuroendocrine tumor cell proliferation in an Rb1-dependent mannerSEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) 2014The epidemiology of neuroendocrine tumors in Taiwan: a nation-wide cancer registry-based study.A clinical and radiological objective tumor response with somatostatin analogs (SSA) in well-differentiated neuroendocrine metastatic tumor of the ileum: a case report.Comparison study of gastrinomas between gastric and non-gastric origins.Diagnostic work-up of gastroenteropancreatic neuroendocrine tumors.SATB2 is a sensitive marker for lower gastrointestinal well-differentiated neuroendocrine tumorsResults of a prospective multicenter neuroendocrine tumor registry reporting on clinicopathologic characteristics of Greek patients.Retrospective analysis of the clinicopathological characteristics of gastrointestinal neuroendocrine neoplasmsSurgical treatment and prognosis of gastric neuroendocrine neoplasms: a single-center experience.Management of controversial gastroenteropancreatic neuroendocrine tumour clinical situations with somatostatin analogues: results of a Delphi questionnaire panel from the NETPraxis program.Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000-2009: Multicenter Study.Long-term outcomes and prognostic factors in 78 Japanese patients with advanced pancreatic neuroendocrine neoplasms: a single-center retrospective study.Analysis of the factors affecting lymph node metastasis and the prognosis of rectal neuroendocrine tumors.Clinical experience in appendiceal neuroendocrine neoplasms.Extensive multiarterial resection attending total duodenopancreatectomy and adrenalectomy for MEN-1-associated neuroendocrine carcinomas.Successful treatment of gallbladder mixed adenoneuroendocrine carcinoma with neo-adjuvant chemotherapy.Role of radiotherapy for pancreatobiliary neuroendocrine tumors.Consensus on biomarkers for neuroendocrine tumour diseaseA Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management
P2860
Q26752380-2906E18E-FA77-4828-BACF-D95108EF8500Q26768483-F64F39C2-70FA-4D6F-8E4A-5D394B09EFAAQ26998392-D421E00B-631E-4068-8731-D471BC268F10Q28083433-153567AF-C1A8-45E3-99B4-AA169219BC30Q30252003-C2FF35F5-DEB4-4749-92EE-77FEA64CADA8Q33591842-A2BCE083-6622-4057-839F-7D8C44EF2A1DQ33798859-4D259FE5-804C-4235-AB17-D3AF4C018637Q33823783-B2779432-039F-4C2F-B852-6420706C1354Q33901099-183E1076-609C-4F39-9D25-AF8677CCA28AQ33932715-581B35C1-BE17-496E-B660-2550AC1F77ADQ33936290-759F4343-5997-4DEE-ABA6-381707F64B3EQ34036704-97835524-B440-4744-9096-1EDDBEBB8C89Q34130243-2C4AB7C1-4225-4FE5-A9A0-EDDDF926DC1BQ34157385-DF8CC950-4A5A-421A-8C3A-B1A71D85F432Q34248466-B80D1FA0-773F-4BF3-8EA1-ADCCAD069277Q34248487-EE5AAE33-BF50-4E28-B00D-967B6A065FC3Q34253861-41D21BF3-A8F0-4D14-9222-88368E62E720Q34254273-D6FDA017-3436-4525-892F-522843ED6331Q34387994-73B3B516-4985-405A-BCFA-DBB625266D90Q34495609-D96FCDC2-4FFB-4D88-89AB-92B27D6DADCDQ34518263-93C32879-BE75-4BC7-A9EF-BCEB8ADE7C02Q34553547-C6E12A45-B1E1-445B-9BE3-8B9DBBF6224DQ34685863-7461C0A0-173A-42C6-9E0C-11C084D2C3BCQ35284530-1643A99F-19FD-4432-B465-358B93DD16BFQ35774521-19F5E7DB-1056-449B-AE37-AC88420D85B3Q35895493-719B611E-1497-4F1A-AE2F-D5104CE22607Q35919281-76639D76-DF95-4BD6-B75A-09F8E8E2C027Q35922755-9822F8F9-99C1-4E9D-A5E8-C32CCB372BD5Q35942994-14FFB941-EEED-4636-AB73-A24ACA953D8EQ36129201-A183123A-B75C-40A3-BED7-850F85449CD4Q36184629-3C8A0BFA-F34A-4729-ADFB-47ACAADB2C5DQ36306654-E553FDE2-5F1E-42CA-A13C-ADD275019697Q36344419-B7DC8BEC-33B7-4A61-9C13-1C79BBC0F82FQ36375451-E87DB3C5-4C88-4150-B690-825AAE1F04CDQ36452893-36E24F9B-09EA-4F4E-96DA-A7FFB17F875CQ36638258-D6468B51-4B76-49FC-8FDF-AE23B2753935Q36646862-A072E5BD-F50A-4743-912B-AED12B3CED3CQ37231180-1E582EFB-1CEF-496F-8D02-15F74A220B74Q37255681-9CB9831B-1A97-4C5B-9C8B-46306CA90A18Q37302087-B317F62B-D994-44D8-B1D5-9ABC0CA50E63
P2860
Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Incidence, patterns of care an ...... er Registry of Spain (RGETNE).
@en
Incidence, patterns of care an ...... er Registry of Spain (RGETNE).
@nl
type
label
Incidence, patterns of care an ...... er Registry of Spain (RGETNE).
@en
Incidence, patterns of care an ...... er Registry of Spain (RGETNE).
@nl
prefLabel
Incidence, patterns of care an ...... er Registry of Spain (RGETNE).
@en
Incidence, patterns of care an ...... er Registry of Spain (RGETNE).
@nl
P2093
P2860
P50
P356
P1433
P1476
Incidence, patterns of care an ...... cer Registry of Spain (RGETNE)
@en
P2093
A Beguiristain-Gómez
C Villabona-Artero
D Castellano
G Crespo-Herrero
I Sevilla-García
J A Díaz-Pérez
J Capdevila
J Sastre-Valera
M Benavent-Viñuelas
P2860
P304
P356
10.1093/ANNONC/MDQ022
P577
2010-02-05T00:00:00Z